Delivery Order SPE2DB22D1106-SPE2DB25FFCP6
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ovidrel 250 mcg/0.5 mL syringes, with a contract ceiling value of $3,323.09. The award was made on July 25, 2025, with an ultimate completion date of July 28, 2025, under a firm fixed price delivery order with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $4,222.90 to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Ovidrel 250 mcg/0.5 mL syringes. This firm fixed-price contract, with an ultimate completion date of August 26, 2025, represents a single-line delivery under a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform delivery from its corporate office location in the same municipality. This...
- The Defense Logistics Agency awarded a delivery order valued at $4,765.72 to AmerisourceBergen Drug Corp for the supply of Ovidrel 250 mcg/0.5 mL syringes with a completion date of September 8, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing for the pharmaceutical product delivery, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,361.44 to AmerisourceBergen Drug Corp for the supply of Ovidrel 250 mcg/0.5 mL syringes. This is a firm fixed price, non-set-aside delivery order that was awarded on July 31, 2025, with an ultimate completion date of August 1, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Ovidrel is a fertility medication containing human chorionic gonadotropin used in...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency for OVIDREL 250 MCG/0.5 ML syringes valued at $1,259.20 with a firm fixed price structure. The award, issued on July 26, 2025, is a non-set-aside competitive contract with an ultimate completion date of July 28, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office operations serving federal medical...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 8, 2025, for Ovidrel 250 mcg/0.5 ml syringes. The contract is valued at $2,189.70 and carries a firm fixed price structure with an ultimate completion date of August 11, 2025. This delivery order represents a non-set-aside award issued under competitive procedures, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $170 to Amerisourcebergen Drug Corporation for Ovidrel 250 mcg/0.5 ml syringes. The delivery order was issued against an undisclosed governmentwide acquisition contract vehicle or indefinite delivery/indefinite quantity contract held by Amerisourcebergen. Performance will occur in Conshohocken, Pennsylvania by August 1, 2023. No subcontractors or set aside designations were...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is a firm fixed price delivery order for the provision of Ovidrel 250 mcg/0.5 ml syringes. The award has a ceiling value of $3,171.60 and a performance period through April 12, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to...
- The Defense Logistics Agency awarded a $4,085.64 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561866982 Ovidrel 250 mcg/0.5 ml syringes. The delivery order was issued against an existing prime vendor contract vehicle and calls for the delivery of 0.5 ml syringes of Ovidrel, a gonadotropin-releasing hormone drug used to induce ovulation, to a facility in Conshohocken, Pennsylvania by August 21, 2023. No subcontractors or set aside designations were...
- The Defense Logistics Agency awarded a $2,975.92 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561653371 Ovidrel 250 mcg/0.5 ml syringes. The delivery order, issued under an undisclosed agency-wide contract vehicle, calls for the delivery of 0.5 ml syringes of Ovidrel, a gonadotropin-releasing hormone drug used to induce ovulation during fertility treatments, to a facility in Conshohocken, Pennsylvania. No subcontractors or set-aside designations were...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFCP6Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of Ovidrel 250 mcg/0.5 mL syringes, with a ceiling value of $4,201.80. The contract is a firm fixed price delivery order with an ultimate completion date of August 12, 2025, awarded on August 11, 2025. This award carries no set-aside designation and represents a competitively awarded transaction. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive prime vendor contract vehicle enables AmerisourceBergen Drug Corp to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including deliveries to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The Ovidrel delivery exemplifies the company's role in fulfilling federal medical procurement requirements across diverse therapeutic domains through DLA's Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 8/11/25 |